Sign in

CIK 0001745999

  • Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,193,310
in 2 filings, $1.2M under 10b5-1 plans

Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-16 Evans John M. CEO Exercise or conversion 10b5-1 +25,000 $1.03 $26K 1,072,205
2026-10-16 Evans John M. CEO Sale 10b5-1 −25,000 $23.98 $600K 1,047,205
2026-10-16 Evans John M. CEO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −25,000 155,804
2026-10-15 Evans John M. CEO Exercise or conversion 10b5-1 +25,000 $1.03 $26K 1,072,205
2026-10-15 Evans John M. CEO Sale 10b5-1 −25,000 $23.57 $589K 1,047,205
2026-10-15 Evans John M. CEO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −25,000 180,804
2026-06-30 Evans John M. CEO Exercise or conversion 10b5-1 +25,000 $1.03 $26K 1,072,205
2026-06-30 Evans John M. CEO Sale 10b5-1 −23,100 $34.26 $791K 1,049,105
2026-06-30 Evans John M. CEO Sale 10b5-1 −1,900 $34.84 $66K 1,047,205
2026-06-30 Evans John M. CEO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −25,000 205,804
2026-06-29 Evans John M. CEO Exercise or conversion 10b5-1 +18,663 $0.67 $13K 1,065,868
2026-06-29 Evans John M. CEO Exercise or conversion 10b5-1 +6,337 $1.03 $7K 1,072,205
2026-06-29 Evans John M. CEO Sale 10b5-1 −13,421 $35.13 $472K 1,058,784
2026-06-29 Evans John M. CEO Sale 10b5-1 −11,579 $35.91 $416K 1,047,205
2026-06-29 Evans John M. CEO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −18,663 9
2026-06-29 Evans John M. CEO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −6,337 230,804
2026-04-01 Evans John M. CEO Sale 10b5-1 −30,078 $24.58 $739K 1,047,205
2026-03-31 Evans John M. CEO Exercise or conversion 10b5-1 +25,000 $0.67 $17K 1,011,667
2026-03-31 Evans John M. CEO Sale 10b5-1 −25,000 $22.76 $569K 986,667
2026-03-31 Evans John M. CEO Grant or award 10b5-1 +90,000 1,076,667

Page 1 of 9 · 173 trades